Cerity Partners LLC boosted its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 7.1% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,643 shares of the medical instruments supplier's stock after buying an additional 242 shares during the quarter. Cerity Partners LLC's holdings in Mettler-Toledo International were worth $4,302,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. Axxcess Wealth Management LLC grew its stake in shares of Mettler-Toledo International by 2.1% during the 1st quarter. Axxcess Wealth Management LLC now owns 888 shares of the medical instruments supplier's stock valued at $1,049,000 after acquiring an additional 18 shares during the period. Linden Thomas Advisory Services LLC grew its stake in shares of Mettler-Toledo International by 5.8% during the 1st quarter. Linden Thomas Advisory Services LLC now owns 1,465 shares of the medical instruments supplier's stock valued at $1,730,000 after acquiring an additional 80 shares during the period. Greenleaf Trust grew its stake in shares of Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock valued at $1,030,000 after acquiring an additional 10 shares during the period. DekaBank Deutsche Girozentrale grew its stake in shares of Mettler-Toledo International by 0.7% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 28,613 shares of the medical instruments supplier's stock valued at $33,351,000 after acquiring an additional 192 shares during the period. Finally, Walter Public Investments Inc. grew its stake in shares of Mettler-Toledo International by 5.6% during the 1st quarter. Walter Public Investments Inc. now owns 7,841 shares of the medical instruments supplier's stock valued at $9,260,000 after acquiring an additional 416 shares during the period. Hedge funds and other institutional investors own 95.07% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on the company. Robert W. Baird decreased their price target on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a report on Tuesday, April 22nd. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their target price for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Barclays initiated coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price on the stock. Bank of America lifted their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. Finally, Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a report on Monday, April 7th. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $1,280.90.
Get Our Latest Analysis on MTD
Mettler-Toledo International Stock Down 0.7%
Shares of MTD stock traded down $8.44 during trading hours on Friday, hitting $1,197.24. 93,366 shares of the company's stock were exchanged, compared to its average volume of 150,949. The firm has a market cap of $24.88 billion, a P/E ratio of 29.86, a P/E/G ratio of 3.71 and a beta of 1.37. The firm has a 50 day moving average of $1,175.85 and a two-hundred day moving average of $1,194.11. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.90 by $0.29. The company had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The firm's quarterly revenue was down 4.6% on a year-over-year basis. During the same period in the prior year, the business earned $8.89 EPS. On average, equities analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the sale, the director owned 120 shares of the company's stock, valued at $139,191.60. This trade represents a 89.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.94% of the stock is owned by company insiders.
About Mettler-Toledo International
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Recommended Stories

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.